Everest Group Recognises Indegene as Front-Runner in GenAI Life Sciences Market Adoption
The report highlights how Indegene’s holistic GenAI strategy and enterprise-grade, production-ready solutions are helping life sciences companies streamline operations and realize strong productivity improvements across several use cases, spanning the clinical, medical and commercial elements of the life sciences value chain.
Generative AI | 12/02/2025 | By Aishwarya
Indegene to Host Sixth Edition of Indegene Digital Summit for Pharma Leaders
This year’s edition offers practitioners' perspectives on key topics such as Generative AI, Advanced Analytics, Technology Transformation and Operations Transformation.
Generative AI | 11/10/2024 | By Aishwarya
Lilly and OpenAI to Revolutionize Medicines to Treat Drug-Resistant Bacteria
Eli Lilly and Company has signed a collaboration deal with OpenAI that will allow Lilly to leverage OpenAI's generative AI to invent novel antimicrobials to treat drug-resistant pathogens.
Generative AI | 26/06/2024 | By Aishwarya | 247
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy